LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
US Federal US
Legislatures
2025-2026 Regular Session
House
Bills
HB2471
US
US Federal House Bill HB2471
US Federal 2025-2026 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
US
US Federal 2025-2026 Regular Session
US Federal House Bill HB2471
Introduced
3/27/25
Refer
3/27/25
Caption
Right Drug Dose Now Act of 2025
Congress_id
119-HR-2471
Policy_area
Health
Introduced_date
2025-03-27
Latest US HB2471 Activity
View All Events: US 2025-2026 Regular Session HB2471
Companion Bills
No companion bills found.
Previously Filed As
US HB5133
Patients’ Right to Know Their Medication Act of 2025
US SB3308
Artificial Intelligence Civil Rights Act of 2025
US HB6356
Artificial Intelligence Civil Rights Act of 2025
US HB4101
Cancer Drug Parity Act of 2025
US SB563
Ohkay Owingeh Rio Chama Water Rights Settlement Act of 2025
US SB705
Innovation in Pediatric Drugs Act of 2025
US SB0282
Compounding drugs; registration of medical spas.
US SB564
Zuni Indian Tribe Water Rights Settlement Act of 2025
US HB3971
Domestic Workers Bill of Rights Act
US SB3396
Domestic Workers Bill of Rights Act
Similar Bills
NJ SJR31
Establishes New Jersey Pharmacogenomics Commission.
OK SB29
Health care; requiring licensed practitioners to offer pharmacogenomic test prior to prescription of psychotropic drugs. Effective date.
OK SB29
Health care; requiring licensed practitioners to offer pharmacogenomic test prior to prescription of psychotropic drugs. Effective date.
OH SB387
Regards Medicaid managed care coverage of pharmacogenomic testing
MD SB608
Maryland Medical Assistance Plan and Health Insurance - Pharmacogenomic Testing - Required Coverage
MD SB961
Maryland Medical Assistance Program and Health Insurance - Pharmacogenomic Testing - Required Coverage
TN HJR0315
A RESOLUTION to recognize Hoskins Drug Store on the occasion of its ninety-fifth anniversary.
NE LB77
Adopt the Ensuring Transparency in Prior Authorization Act and provide for insurance and medicaid coverage of biomarker testing